SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
NYSE New York Stock Exchange
Börse NYSE New York Stock Exchange
ISIN US7170811035
USD
  • Pfizer
    Börse NYSE New York Stock Exchange
    ISIN US7170811035 WKN: 852009
    Symbol PFE
    USD
  • Pfizer
    Börse Börse Stuttgart
    ISIN US717081DK61
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081ER06
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Hamburg
    ISIN US717081ED10
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Düsseldorf
    ISIN XS1574158082
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse München
    ISIN US717081DZ31
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Gettex System der Börse München
    ISIN US717081ES88
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US717081EQ23
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US717081DE02
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Frankfurt
    ISIN XS1574157357
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081EY56
    EUR
  • Pfizer
    Börse Börse München
    ISIN US717081FA61
    EUR
  • Pfizer
    Börse SSE Stockholm Stock Exchange
    ISIN US717081EZ22
    Symbol PFE
    SEK
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081EK52
    Symbol PFE
    MXN
  • Pfizer
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US717081DV27
    USD
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081DH33
    MXN
  • Pfizer
    Börse BUE
    ISIN US717081EV18
    USD
  • ISIN US717081EX73
    Symbol PFE
    EUR
  • Pfizer
    Börse OMXS
    ISIN US7170811035
    SEK
  • ISIN US717081EJ89
    EUR
  • PFIZER INC
    Börse SSE
    ISIN US717081EP40
ISIN US7170811035
WKN 852009
Symbol PFE
Währung USD
Börse NYSE New York Stock Exchange Zeitzone: Europe/Berlin
Firmenname Pfizer Inc
Marktkapitalisierung 197.500.079.920 (+- 10%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

204.882.624.512 oder 216.419.000.000 oder 171.198.615.249

Mitarbeiter 83.400 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

88.300 oder 78.500 Mitarbeiter

Anzahl Aktien 5.558.396.599
KGV 18.68 (+- 28%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

23.97 oder 13.4

EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744

Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 USD . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Die Dividendenrendite entsprach 4,02 % p. a. beim aktuellen Kurs von 36,59 USD -0,04% 

Pfizer underperformed den DAX um -9 % (+35 % Dividenden) vom 15.10.2013 bis 14.09.2021

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 36,59 USD -0,04% 

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Pfizer abonniert.

Aktionärsstruktur der Pfizer Inc

957 News & Informationen zur Pfizer Aktie

  • Outlook On The End Stage Renal Disease Global Market To 2025 - Competitive Analysis And Impact Of COVID-19
    thestreet.com

    Outlook On The End Stage Renal Disease Global Market To 2025 – Competitive Analysis And Impact Of COVID-19

    DUBLIN, April 13, 2021 /PRNewswire/ — The “Global End Stage Renal Disease Market (2020-2025) by Disease Type, Treatment Type, End User, Geography, Competitive

  • S&P 500 Posts New Record High, Tesla Skyrockets Despite Worse-Than-Feared Inflation Data And Vaccine Concerns
    forbes.com

    S&P 500 Posts New Record High, Tesla Skyrockets Despite Worse-Than-Feared Inflation Data And Vaccine Concerns

    Gasoline prices spiked more than 9% last month.

  • Johnson & Johnson Covid-19 Vaccine Pause Disrupts Appointments in New York Region
    marketscreener.com

    Johnson & Johnson Covid-19 Vaccine Pause Disrupts Appointments in New York Region

    By Kate King

    Thousands of Covid-19 vaccination appointments had to be rescheduled across the tri-state region Tuesday after governors said they would pause giving Johnson & Johnson's… | April 13, 2021

  • S&P 500 Inches to Record High, but Vaccine Setback Keeps Lid on Gains By Investing.com
    investing.com

    S&P 500 Inches to Record High, but Vaccine Setback Keeps Lid on Gains By Investing.com

    S&P 500 Inches to Record High, but Vaccine Setback Keeps Lid on Gains

  • Myovant (MYOV), Pfizer Start Dosing in Relugolix Combo Study
    zacks.com

    Myovant (MYOV), Pfizer Start Dosing in Relugolix Combo Study

    Myovant (MYOV) and Pfizer (PFE) initiate dosing in the phase III SERENE study evaluating the contraceptive efficacy of the relugolix combination tablet.

  • South Africa regulator to discuss Johnson & Johnson shot after US pause
    livemint.com

    South Africa regulator to discuss Johnson & Johnson shot after US pause

    South African health authorities and scientists will meet Wednesday to discuss the US decision to suspend use of Johnson & Johnson’s Covid-19 vaccine after it was linked to rare blood clots.

  • Nasdaq leads as Johnson & Johnson weighs on Dow, S&P
    news.google.com

    Nasdaq leads as Johnson & Johnson weighs on Dow, S&P

    J&J is a drag on the Dow as the U.S. Food and Drug Administration recommended a pause of its COVID-19 vaccine.

  • Dow Falls 200 Points After Worse-Than-Feared Inflation Data And Johnson & Johnson Vaccine Concerns
    forbes.com

    Dow Falls 200 Points After Worse-Than-Feared Inflation Data And Johnson & Johnson Vaccine Concerns

    Gasoline prices spiked more than 9% last month.

  • Chart Of The Day: Fundamentals And Technicals Agree, Pfizer Is Heading Higher
    investing.com

    Chart Of The Day: Fundamentals And Technicals Agree, Pfizer Is Heading Higher

    Stocks Analysis by Pinchas Cohen/Investing.com covering: Pfizer Inc, Johnson & Johnson, AstraZeneca PLC ADR, Moderna Inc. Read Pinchas Cohen/Investing.com's latest article on Investing.com

  • Johnson & Johnson Covid-19 Vaccine Updates: Lower Weekly Supply, Blood Clot Investigations
    forbes.com

    Johnson & Johnson Covid-19 Vaccine Updates: Lower Weekly Supply, Blood Clot Investigations

    Johnson & Johnson began the rollout of its single-dose Covid-19 vaccine in the United States in early March 2021. Below are some of the recent updates relating to the vaccine. The supply of J&J’s Covid-19 vaccine is expected to decline by about 85% in the U.S. this week, as the company faces some…

  • A Short Delay Is Still Bad News for AbbVie
    fool.com

    A Short Delay Is Still Bad News for AbbVie

    Rinvoq's FDA approval decision could be a sign the drug class is under investigation.

  • J&J Slips As Adverse Reactions Force FDA To Put Pause On Its Covid Jabs By Investing.com
    investing.com

    J&J Slips As Adverse Reactions Force FDA To Put Pause On Its Covid Jabs By Investing.com

    J&J Slips As Adverse Reactions Force FDA To Put Pause On Its Covid Jabs

  • 3 Beaten-Down Biotech Stocks: Can They Recover?
    fool.com

    3 Beaten-Down Biotech Stocks: Can They Recover?

    These drugmaker stocks may have been hammered down to bargain-bin prices.

  • India's Covid crisis stems from arrogance, hyper-nationalism, incompetence
    business-standard.com

    India's Covid crisis stems from arrogance, hyper-nationalism, incompetence

    Read more about India's Covid crisis stems from arrogance, hyper-nationalism, incompetence on Business Standard. Regulatory uncertainty, bullying, and contempt for legitimate profit-making is familiar to every entrepreneur in India.

  • B.C. to target specific neighbourhoods for COVID-19 vaccinations
    biv.com

    B.C. to target specific neighbourhoods for COVID-19 vaccinations

    Taking a cue from Ontario, B.C.’s top doctor says the West Coast will begin targeting specific neighbourhoods for COVID-19 vaccinations.

  • COVID-19 cases keep surging in some U.S. states, and Michigan governor continues plea for more vaccines as shots in arms hits daily record
    marketwatch.com

    COVID-19 cases keep surging in some U.S. states, and Michigan governor continues plea for more vaccines as shots in arms hits daily record

    The U.S. is facing another surge in new COVID-19 cases in some states, led by Michigan, but the White House has spurned Michigan Gov. Gretchen Whitmer…

  • Why the Mutated Coronavirus Variants Are So Worrisome
    washingtonpost.com

    Why the Mutated Coronavirus Variants Are So Worrisome

    Viruses mutate all the time, including the novel coronavirus that’s caused the global Covid-19 pandemic. Most of the changes have no apparent effect. But recent variants that have emerged in the U.K., South Africa and Brazil are causing particular concern.

  • 5 Inverse/Leveraged ETF Areas of Last Week
    investing.com

    5 Inverse/Leveraged ETF Areas of Last Week

    Stocks Analysis by Zacks Investment Research covering: US Small Cap 2000, Pfizer Inc, NASDAQ Composite, Moderna Inc. Read Zacks Investment Research's latest article on Investing.com

  • What’s the Best Covid Vaccine? Why It’s Not So Simple
    washingtonpost.com

    What’s the Best Covid Vaccine? Why It’s Not So Simple

    As scientists raced to develop Covid-19 vaccines, public health specialists were hoping that more than one group would succeed. Having multiple companies producing vaccines would make it easier to inoculate a lot of people fast. Be careful what you wish for. A range of vaccines with different efficacy results now has given rise to worries that some people may refuse the shot on offer in hopes of getting a “better” one later. In reality, comparing efficacy numbers isn’t necessarily the best way t

  • 5 things to know before the stock market opens Monday
    cnbc.com

    5 things to know before the stock market opens Monday

    U.S. stock futures slipped Monday after Friday's rally on Covid reopening optimism lifted the Dow and S&P 500 to record closes.

  • Celcuity (CELC) Soars on Agreement With Pfizer & Study Data
    zacks.com

    Celcuity (CELC) Soars on Agreement With Pfizer & Study Data

    Celcuity (CELC) is developing gedatolisib in combination with Pfizer's Ibrance and an endocrine therapy in breast cancer patients. It inks deal to gain exclusive rights to gedatolisib from Pfizer.

  • Capital Markets Look For Direction
    investing.com

    Capital Markets Look For Direction

    Forex Analysis by Marc Chandler covering: EUR/USD, GBP/USD, USD/JPY, AUD/USD. Read Marc Chandler's latest article on Investing.com

  • Pfizer's About to Cut Its Dividend: What You Need to Know
    fool.com

    Pfizer's About to Cut Its Dividend: What You Need to Know

    The big drugmaker's dividend won't remain at its current level for much longer.

  • Asia Gets Ali Ba-Bashed; Economic Data Expectations
    investing.com

    Asia Gets Ali Ba-Bashed; Economic Data Expectations

    Market Overview Analysis by MarketPulse (Jeffrey Halley) covering: USD/INR, Pfizer Inc, Johnson & Johnson, United States 10-Year. Read MarketPulse (Jeffrey Halley)'s latest article on Investing.com

  • Covid: Brazilian phase 3 study shows China's Sinovac jab has 50.7% efficacy
    business-standard.com

    Covid: Brazilian phase 3 study shows China's Sinovac jab has 50.7% efficacy

    Read more about Covid: Brazilian phase 3 study shows China's Sinovac jab has 50.7% efficacy on Business Standard. The study, which was posted online and hasn't yet been reviewed by independent scientists, showed the vaccine was more effective at protecting against dangerous infections

  • Specialty Generics Market 2021 Size, Growth Analysis Report, Forecast & Expert Review | Valeant Pharmaceuticals International, Inc.,...
    globalbankingandfinance.com

    Specialty Generics Market 2021 Size, Growth Analysis Report, Forecast & Expert Review | Valeant Pharmaceuticals International, Inc., Novartis | FMI

    Specialty Generics market players – Valeant Pharmaceuticals International, Inc., Novartis,Pfizer Inc., Turing Pharmaceuticals, Teva Pharmaceutical Ltd among

  • China considering mixing COVID-19 vaccines to boost protection rate By Reuters
    investing.com

    China considering mixing COVID-19 vaccines to boost protection rate By Reuters

    China considering mixing COVID-19 vaccines to boost protection rate

  • U.S. has administered 187 million doses of COVID-19 vaccines, CDC says By Reuters
    investing.com

    U.S. has administered 187 million doses of COVID-19 vaccines, CDC says By Reuters

    U.S. has administered 187 million doses of COVID-19 vaccines, CDC says

  • Chile defends Sinovac use amid fresh efficacy questions By Reuters
    investing.com

    Chile defends Sinovac use amid fresh efficacy questions By Reuters

    'The right path' – Chile defends Sinovac use amid fresh efficacy questions

  • 3 Hot Penny Stocks To Watch With Important Biotech Events In April 2021
    pennystocks.com

    3 Hot Penny Stocks To Watch With Important Biotech Events In April 2021

    Putting a list of penny stocks together focusing on biotech? These 3 companies have upcoming events in April 2021 to be aware of right now.

  • US Indexes End with Gains Friday
    gurufocus.com

    US Indexes End with Gains Friday

    US Indexes End with Gains Friday, Stocks: AAPL,SOXX,EADSY,BA,JNJ,PFE,AMZN,F,GM,INTC, release date:Apr 11, 2021

  • 3 Great Dividend Stocks to Buy Right Now
    fool.com

  • U.S. has administered 183.5 million doses of COVID-19 vaccines, CDC says By Reuters
    investing.com

    U.S. has administered 183.5 million doses of COVID-19 vaccines, CDC says By Reuters

    U.S. has administered 183.5 million doses of COVID-19 vaccines, CDC says

  • South African variant can 'break through' Pfizer vaccine, Israeli study says By Reuters
    investing.com

    South African variant can 'break through' Pfizer vaccine, Israeli study says By Reuters

    South African variant can 'break through' Pfizer vaccine, Israeli study says

  • 6 Pet Stocks And An ETF For National Pet Day
    markets.businessinsider.com

    6 Pet Stocks And An ETF For National Pet Day

    National Pet Day was created in 2006 to bring awareness to adopting and spoiling pets. The holiday takes place every year on April 11. Here is a …

  • Biden’s orphaned AstraZeneca supply rises to 20 million doses
    businessmirror.com.ph

    Biden’s orphaned AstraZeneca supply rises to 20 million doses

    The US stockpile of the controversial AstraZeneca Plc coronavirus vaccine has grown to more than 20 million doses, according to people familiar with the matter, even as the shot looks increasingly unlikely to factor into President Joe Biden’s domestic vaccination campaign. AstraZeneca has yet to request Food and Drug Administration…

  • DD on Novartis (NVS), and their role in the treatment of opioid dependence disorder : investing
    reddit.com

    DD on Novartis (NVS), and their role in the treatment of opioid dependence disorder : investing

    This is my first DD post, so bear (or bull) with me (C+C appreciated, as I had a lot of fun researching and writing this) Stock Ticker: NVS Market …

  • BioNTech-Aktie weit im Plus: BioNTech und Pfizer wollen Impfstoff in den USA ab 12 Jahren einsetzen
    finanzen.net

    BioNTech-Aktie weit im Plus: BioNTech und Pfizer wollen Impfstoff in den USA ab 12 Jahren einsetzen

    Die Hersteller Pfizer und BioNTech wollen ihren Corona-Impfstoff in den USA künftig auch bei Jugendlichen ab zwölf Jahren einsetzen. 10.04.2021

  • 3 Stocks That Could Suffer if Biden Gives In to This Pressure
    fool.com

    3 Stocks That Could Suffer if Biden Gives In to This Pressure

    Leaders from across the globe and at home want the new president to break from his past.

  • 3 Top Healthcare Growth Stocks to Buy for April
    fool.com

    3 Top Healthcare Growth Stocks to Buy for April

    These companies are at the forefront of innovation in the healthcare sector, and their stocks are surprisingly affordable too.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Pfizer Aktie

Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.

Die Pfizer Aktie hat inklusive der Dividendenausschüttungen seit dem 15.10.2013 eine Gesamtrendite von 104% erwirtschaftet

Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero